#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Haploid Genetic Screens Identify an Essential Role for PLP2 in the Downregulation of Novel Plasma Membrane Targets by Viral E3 Ubiquitin Ligases


The Kaposi's sarcoma-associated herpesvirus gene products K3 and K5 are viral ubiquitin E3 ligases which downregulate MHC-I and additional cell surface immunoreceptors. To identify novel cellular genes required for K5 function we performed a forward genetic screen in near-haploid human KBM7 cells. The screen identified proteolipid protein 2 (PLP2), a MARVEL domain protein of unknown function, as essential for K5 activity. Genetic loss of PLP2 traps the viral ligase in the endoplasmic reticulum, where it is unable to ubiquitinate and degrade its substrates. Subsequent analysis of the plasma membrane proteome of K5-expressing KBM7 cells in the presence and absence of PLP2 revealed a wide range of novel K5 targets, all of which required PLP2 for their K5-mediated downregulation. This work ascribes a critical function to PLP2 for viral ligase activity and underlines the power of non-lethal haploid genetic screens in human cells to identify the genes involved in pathogen manipulation of the host immune system.


Vyšlo v časopise: Haploid Genetic Screens Identify an Essential Role for PLP2 in the Downregulation of Novel Plasma Membrane Targets by Viral E3 Ubiquitin Ligases. PLoS Pathog 9(11): e32767. doi:10.1371/journal.ppat.1003772
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003772

Souhrn

The Kaposi's sarcoma-associated herpesvirus gene products K3 and K5 are viral ubiquitin E3 ligases which downregulate MHC-I and additional cell surface immunoreceptors. To identify novel cellular genes required for K5 function we performed a forward genetic screen in near-haploid human KBM7 cells. The screen identified proteolipid protein 2 (PLP2), a MARVEL domain protein of unknown function, as essential for K5 activity. Genetic loss of PLP2 traps the viral ligase in the endoplasmic reticulum, where it is unable to ubiquitinate and degrade its substrates. Subsequent analysis of the plasma membrane proteome of K5-expressing KBM7 cells in the presence and absence of PLP2 revealed a wide range of novel K5 targets, all of which required PLP2 for their K5-mediated downregulation. This work ascribes a critical function to PLP2 for viral ligase activity and underlines the power of non-lethal haploid genetic screens in human cells to identify the genes involved in pathogen manipulation of the host immune system.


Zdroje

1. RandowF, LehnerPJ (2009) Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11: 527–534.

2. CoscoyL, GanemD (2000) Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97: 8051–8056.

3. IshidoS, WangC, LeeBS, CohenGB, JungJU (2000) Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74: 5300–5309.

4. LehnerPJ, HoerS, DoddR, DuncanLM (2005) Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207: 112–125.

5. SanchezDJ, GumperzJE, GanemD (2005) Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115: 1369–1378.

6. RhodesDA, BoyleLH, BonameJM, LehnerPJ, TrowsdaleJ (2010) Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation. Proc Natl Acad Sci USA 107: 16240–16245.

7. CoscoyL, GanemD (2001) A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 107: 1599–1606.

8. MansouriM, DouglasJ, RosePP, GouveiaK, ThomasG, et al. (2006) Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108: 1932–1940.

9. BarteeE, McCormackA, FrühK (2006) Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2: e107.

10. ThomasM, BonameJM, FieldS, NejentsevS, SalioM, et al. (2008) Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci USA 105: 1656–1661.

11. MansouriM, ViswanathanK, DouglasJL, HinesJ, GustinJ, et al. (2009) Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol 83: 9672–9681.

12. PardieuC, ViganR, WilsonSJ, CalviA, ZangT, et al. (2010) The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog 6: e1000843.

13. HewittEW, DuncanL, MuftiD, BakerJ, StevensonPG, et al. (2002) Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J 21: 2418–2429.

14. BonameJM, ThomasM, StaggHR, XuP, PengJ, et al. (2010) Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 11: 210–220.

15. DuncanLM, PiperS, DoddRB, SavilleMK, SandersonCM, et al. (2006) Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J 25: 1635–1645.

16. GotoE, YamanakaY, IshikawaA, Aoki-KawasumiM, Mito-YoshidaM, et al. (2010) Contribution of lysine 11-linked ubiquitination to MIR2-mediated major histocompatibility complex class I internalization. J Biol Chem 285: 35311–35319.

17. CaretteJE, GuimaraesCP, VaradarajanM, ParkAS, WuethrichI, et al. (2009) Haploid genetic screens in human cells identify host factors used by pathogens. Science 326: 1231–1235.

18. AnderssonBS, BeranM, PathakS, GoodacreA, BarlogieB, et al. (1987) Ph-positive chronic myeloid leukemia with near-haploid conversion in vivo and establishment of a continuously growing cell line with similar cytogenetic pattern. Cancer Genet Cytogenet 24: 335–343.

19. KoteckiM, ReddyPS, CochranBH (1999) Isolation and characterization of a near-haploid human cell line. Exp Cell Res 252: 273–280.

20. CaretteJE, GuimaraesCP, WuethrichI, BlomenVA, VaradarajanM, et al. (2011) Global gene disruption in human cells to assign genes to phenotypes by deep sequencing. Nat Biotechnol 29: 542–546.

21. CaretteJE, RaabenM, WongAC, HerbertAS, ObernostererG, et al. (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477: 340–343.

22. PapatheodorouP, CaretteJE, BellGW, SchwanC, GuttenbergG, et al. (2011) Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci USA 108: 16422–16427.

23. ReilingJH, ClishCB, CaretteJE, VaradarajanM, BrummelkampTR, et al. (2011) A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin. Proc Natl Acad Sci USA 108: 11756–11765.

24. RosmarinDM, CaretteJE, OliveAJ, StarnbachMN, BrummelkampTR, et al. (2012) Attachment of Chlamydia trachomatis L2 to host cells requires sulfation. Proc Natl Acad Sci USA 109: 10059–10064.

25. BirsoyK, WangT, PossematoR, YilmazOH, KochCE, et al. (2013) MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet 45: 104–108.

26. JaeLT, RaabenM, RiemersmaM, Van BeusekomE, BlomenVA, et al. (2013) Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science 340: 479–483.

27. DuncanLM, TimmsRT, ZavodszkyE, CanoF, DouganG, et al. (2012) Fluorescence-based phenotypic selection allows forward genetic screens in haploid human cells. PloS ONE 7: e39651.

28. WeekesMP, TanSYL, PooleE, TalbotS, AntrobusR, et al. (2013) Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science 340: 199–202.

29. UrenAG, MikkersH, KoolJ, Van der WeydenL, LundAH, et al. (2009) A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat Protoc 4: 789–798.

30. WangB, NguyenM, BreckenridgeDG, StojanovicM, ClemonsPA, et al. (2003) Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria. J Biol Chem 278: 14461–14468.

31. NathanJA, LehnerPJ (2009) The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp Cell Res 315: 1593–1600.

32. AnastassiadisK, FuJ, PatschC, HuS, WeidlichS, et al. (2009) Dre recombinase, like Cre, is a highly efficient site-specific recombinase in E. coli, mammalian cells and mice. Dis Model Mech 2: 508–515.

33. BruloisKF, ChangH, LeeAS-Y, EnsserA, WongL-Y, et al. (2012) Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86: 9708–9720.

34. Sánchez-PulidoL, Martín-BelmonteF, ValenciaA, AlonsoMA (2002) MARVEL: a conserved domain involved in membrane apposition events. Trends Biochem Sci 27: 599–601.

35. PaulsonE, TranC, CollinsK, FrühK (2001) KSHV-K5 inhibits phosphorylation of the major histocompatibility complex class I cytoplasmic tail. Virology 288: 369–378.

36. NaslavskyN, WeigertR, DonaldsonJG (2004) Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol Biol Cell 15: 3542–3552.

37. NilssonT, JacksonM, PetersonPA (1989) Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58: 707–718.

38. MunroS, PelhamHR (1987) A C-terminal signal prevents secretion of luminal ER proteins. Cell 48: 899–907.

39. WeekesMP, AntrobusR, LillJR, DuncanLM, HörS, et al. (2010) Comparative analysis of techniques to purify plasma membrane proteins. J Biomol Tech 21: 108–115.

40. WeekesMP, AntrobusR, TalbotS, HörS, SimecekN, et al. (2012) Proteomic plasma membrane profiling reveals an essential role for gp96 in the cell surface expression of LDLR family members, including the LDL receptor and LRP6. J Proteome Res 11: 1475–1484.

41. BreitwieserGE, McLenithanJC, CorteseJF, ShieldsJM, OlivaMM, et al. (1997) Colonic epithelium-enriched protein A4 is a proteolipid that exhibits ion channel characteristics. Am J Physiol 272: C957–65.

42. LeeSM, ShinH, JangS-W, ShimJ-J, SongI-S, et al. (2004) PLP2/A4 interacts with CCR1 and stimulates migration of CCR1-expressing HOS cells. Biochem Biophys Res Commun 324: 768–772.

43. ZhangL, JieC, ObieC, AbidiF, SchwartzCE, et al. (2007) X chromosome cDNA microarray screening identifies a functional PLP2 promoter polymorphism enriched in patients with X-linked mental retardation. Genome Res 17: 641–648.

44. SonodaY, WaritaM, SuzukiT, OzawaH, FukudaY, et al. (2010) Proteolipid protein 2 is associated with melanoma metastasis. Oncol Rep 23: 371–376.

45. ZhangF, FrostAR, BlundellMP, BalesO, AntoniouMN, et al. (2010) A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol Ther 18: 1640–1649.

46. KwonSE, ChapmanER (2011) Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 70: 847–854.

47. AdrainC, ZettlM, ChristovaY, TaylorN, FreemanM (2012) Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335: 225–228.

48. McIlwainDR, LangPA, MaretzkyT, HamadaK, OhishiK, et al. (2012) iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335: 229–232.

49. KimY-M, BrinkmannMM, PaquetM-E, PloeghHL (2008) UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452: 234–238.

50. GilstringCF, Melin-LarssonM, LjungdahlPO (1999) Shr3p mediates specific COPII coatomer-cargo interactions required for the packaging of amino acid permeases into ER-derived transport vesicles. Mol Biol Cell 10: 3549–3565.

51. GeigerR, AndritschkeD, FriebeS, HerzogF, LuisoniS, et al. (2011) BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol. Nat Cell Biol 13: 1305–1314.

52. AnnaertWG, BeckerB, KistnerU, RethM, JahnR (1997) Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J Cell Biol 139: 1397–1410.

53. PaquetM-E, Cohen-DoyleM, ShoreGC, WilliamsDB (2004) Bap29/31 influences the intracellular traffic of MHC class I molecules. J Immunol 172: 7548–7555.

54. BarteeE, EysterCA, ViswanathanK, MansouriM, DonaldsonJG, et al. (2010) Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes. PloS ONE 5: e15132.

55. HörS, ZivT, AdmonA, LehnerPJ (2009) Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase. Mol Cell Proteomics 8: 1959–1971.

56. BornerGHH, AntrobusR, HirstJ, BhumbraGS, KozikP, et al. (2012) Multivariate proteomic profiling identifies novel accessory proteins of coated vesicles. J Cell Biol 197: 141–160.

57. WilkinsonGWG, TomasecP, StantonRJ, ArmstrongM, Prod'hommeV, et al. (2008) Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41: 206–212.

58. PasqualeEB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133: 38–52.

59. TakamatsuH, KumanogohA (2012) Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol 33: 127–135.

60. CoxJ, NeuhauserN, MichalskiA, ScheltemaRA, Olsen JV, et al. (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1794–1805.

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2013 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#